“Health consequences associated with frequent wheezing in adolescents without asthma diagnosis.” K. Yeatts, K. Johnston Davis, D. Peden and C. Shy. Eur Respir J 2003; 22: 781–786. Yeatts Karin
Related content which might interest you:
“Guidelines for the management of work-related asthma.” X. Baur, T. Sigsgaard, T.B. Aasen, P.S. Burge, D. Heederik, P. Henneberger, P. Maestrelli, J. Rooyackers, V. Schlünssen, O. Vandenplas and D. Wilken on behalf of the ERS Task Force on the Management of Work-related Asthma. Eur Respir J 2012; 39: 529–545. Source: Eur Respir J 2012; 39: 1553 Year: 2012
“Effect of different asthma treatments on risk of cold-related exacerbations.” H.K. Reddel, C. Jenkins, S. Quirce, M.R. Sears, E.D. Bateman, P.M. O'Byrne, M. Humbert, R. Buhl, T. Harrison, G.G. Brusselle, A. Thorén, U. Sjöbring, S. Peterson, O. Östlund and G.S. Eriksson. Eur Respir J 2011; 38: 584–593. Source: Eur Respir J 2012; 39: 1280 Year: 2012
“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647. Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019 Year: 2020
“Cellular mechanisms underlying steroid-resistant asthma.” Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro. Eur Respir Rev 2019; 28: 190021. Source: Eur Respir Rev, 28 (154) 195096; 10.1183/16000617.5096-2019 Year: 2019
“Community-acquired pneumonia in younger patients is an entity on its own.” Benjamin Klapdor, Santiago Ewig, Mathias W. Pletz, Gernot Rohde, Hartwig Schütte, Tom Schaberg and Tobias Welte for the CAPNETZ study group. Eur Respir J 2012; 39: 1156–1161. Source: Eur Respir J 2012; 40: 1583 Year: 2012
“Global strategy for asthma management and prevention: GINA executive summary.” E.D. Bateman, S.S. Hurd, P.J. Barnes, J. Bousquet, J.M. Drazen, J.M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S.E. Pedersen, E. Pizzichini, S.D. Sullivan, S.E. Wenzel and H.J. Zar. Eur Respir J 2008; 31: 143–178. Source: Eur Respir J, 51 (2) 0751387; 10.1183/13993003.51387-2007 Year: 2018
“Budesonide/formoterol maintenance, reliever therapy: an effective asthma treatment option?” C. Vogelmeier A. D'Urzo R. Pauwels† J.M. Merino M. Jaspal S. Boutet I. Naya, D. Price. Eur Respir J 2005; 26: 819–828. Source: Eur Respir J 2011; 38: 491 Year: 2011
“Sleep apnoea is associated with major cardiac events in peripheral arterial disease.” Karri T. Utriainen, Juhani K. Airaksinen, Olli Polo, Ruut Laitio, Mikko J. Pietilä, Harry Scheinin, Tero Vahlberg, Kari A. Leino, Erkki S. Kentala, Jouko R. Jalonen, Harri Hakovirta, Riitta Parkkola, Sami Virtanen and Timo T. Laitio. Eur Respir J 2014; 43: 1652-1660. Source: Eur Respir J, 51 (4) 1351309; 10.1183/13993003.51309-2013 Year: 2018
“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784. Source: Eur Respir J 2016; 48: 593 Year: 2016
“The role of nebulised budesonide in the treatment of exacerbations of COPD.” H. Gunen, S.S. Hacievliyagil, O. Yetkin, G. Gulbas, L.C. Mutlu and E. In. Eur Respir J 2007; 29: 660–667. Source: Eur Respir J 2014; 44: 272 Year: 2014
“Blood basophil activation is a reliable biomarker of allergic bronchopulmonary aspergillosis in cystic fibrosis.” Yael Gernez, Jeffrey Waters, Bojana Mirkovic, Gillian M. Lavelle, Colleen E. Dunn, Zoe A. Davies, Cassie Everson, Rabindra Tirouvanziam, Elana Silver, Sylvan Wallenstein, Sanjay H. Chotirmall, Noel G. McElvaney, Leonore A. Herzenberg and Richard B. Moss. Eur Respir J 2016; 47: 177–185. Source: Eur Respir J 2016; 47:1892 Year: 2016
“Sleep apnoea and visceral adiposity in middle-aged male and female subjects.” Ilia Kritikou, Maria Basta, Rafel Tappouni, Slobodanha Pejovic, Julio Fernandez-Mendoza, Racha Nazir, Michelle L. Shaffer, Duanping Liao, Edward O. Bixler, George P. Chrousos and Alexandros N. Vgontzas. Eur Respir J 2013; 41: 601–609. Source: Eur Respir J, 56 (6) 1151834; 10.1183/13993003.51834-2011 Year: 2020
“Exhaled nitric oxide and the risk of wheezing in infancy: the Generation R Study.” C. Gabriele, V.W. Jaddoe, E. van Mastrigt, L.R. Arends, A. Hofman, H.A. Moll and J.C. de Jongste. Eur Respir J 2012; 39: 567–572. Source: Eur Respir J 2012; 39: 1281 Year: 2012
“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057. Source: Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018 Year: 2018
“Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice.” Brigitte Benard, Valérie Bastien, Benjamin Vinet, Roger Yang, Maja Krajinovic and Francine M. Ducharme. Eur Respir J 2017; 50: 1700148. Source: Eur Respir J, 50 (5) 1750148; 10.1183/13993003.50148-2017 Year: 2017
“Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis.” M. Wilschanski, L.L. Miller, D. Shoseyov, H. Blau, J. Rivlin, M. Aviram, M. Cohen, S. Armoni, Y. Yaakov, T. Pugatch, M. Cohen-Cymberknoh, N.L. Miller, A. Reha, V.J. Northcutt, S. Hirawat, K. Donnelly, G.L. Elfring, T. Ajayi and E. Kerem. Eur Respir J 2011; 38: 59–69. Source: Eur Respir J 2011; 38: 996 Year: 2011
Retraction notice for: “Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases.” Theodoros V. Giannouchos, Roberto A. Sussman, José M. Mier, Konstantinos Poulas and Konstantinos Farsalinos. Eur Respir J 2020; in press. Source: Eur Respir J, 57 (3) 2002144; 10.1183/13993003.02144-2020 Year: 2021
“Reproducibility of 6-minute walking test in patients with COPD”. N.A. Hernandes, E.F.M. Wouters, K. Meijer, J. Annegarn, F. Pitta and M.A. Spruit. Eur Respir J 2011; 38: 261–267. Source: Eur Respir J 2012; 40: 1583 Year: 2012
“Triple therapy in idiopathic pulmonary fibrosis: an alarming press release.” A.U. Wells, J. Behr, U. Costabel, V. Cottin and V. Poletti. Eur Respir J 2012; 39: 805–806. Source: Eur Respir J 2012; 39: 1552 Year: 2012
“Contact investigation for tuberculosis: a systematic review and meta-analysis.” Gregory J. Fox, Simone E. Barry, Warwick J. Britton and Guy B. Marks. Eur Respir J 2013; 41: 140–156. Source: Eur Respir J 2015; 46: 578 Year: 2015